Search Results 521-530 of 13334 for Poison+oak

  1. Anesthesiology and Perioperative Medicine - Doctors - Mayo Clinic

    Mayo Clinic's Department of Anesthesiology sees more than 145000 patients each year and integrates patient care, research and education, resulting in ...

  2. Crohn's disease - Doctors and departments - Mayo Clinic

    Learn about symptoms and treatment for this debilitating, but treatable, digestive condition.

  3. Overview - Oncoimmune Signaling and Therapeutics - Mayo Clinic Research

    The laboratory is using new knowledge derived from our research to develop innovative therapeutic approaches to restore antitumor immunity across a range of ...

  4. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  5. Mayo Clinic researchers investigate novel radiopharmaceutical therapy for breast cancer

    Clinical trial will study a potent new treatment that targets the most common subset of breast cancer.

  6. Adult health LGBTQ health - Mayo Clinic

    Poison ivy and other summer skin irritants · Prescription sleeping pills: What's right for you? Protect thin skin · Safe outdoor activities during the COVID-19 ...

  7. Head and neck cancers - Doctors and departments - Mayo Clinic

    Learn about innovative treatment for throat cancers, mouth cancers, tongue cancers, tonsil cancers and other cancers that affect the head and neck.

  8. INCB039110 Combined With INCB024360 and/or INCB039110 Combined With INCB050465 in Advanced Solid Tumors - Mayo Clinic

    Part 1a will evaluate a JAK inhibitor with JAK1 selectivity (INCB039110) in combination with an IDO1 inhibitor (epacadostat; INCB024360; Group A) and INCB039110 ...

  9. Head and neck cancers - Doctors and departments - Mayo Clinic

    Learn about innovative treatment for throat cancers, mouth cancers, tongue cancers, tonsil cancers and other cancers that affect the head and neck.

  10. Study Of CG0070 Given In Combination With Pembrolizumab, In Non Muscle Invasive Bladder Cancer, Unresponsive To Bacillus Calmette-Guerin - Mayo Clinic

    Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...